web analytics
10.1 C
Friday, October 7, 2022

Riding the NuGene International Inc (OTCBB:NUGN) Hard Mailer Express

NuGene International Inc (OTCBB:NUGN) is making spectacular moves and topping the bb’s in trades doing millions in dollar volume.

NUGN is a major hard mailer promotion featuring Kathy Ireland and the headline ”Did Kathy Ireland just discover Botox without the needle? Super model Kathy Ireland sells an estimated $2b at retail annually and just partnered with NUGN.”” it then makes the preposterous prediction that ”shares could fly from $1.27 to $25.08.”

NuGene International Inc (OTCBB:NUGN) bills itself as a developer, manufacturer and marketer of advanced skin and hair care lines utilizing adipose derived human stem cells and stem cell media.

According to NUGN the US Department of Health and Human Services calls regenerative medicine the “next evolution of medical treatments.” The regenerative medical market, which includes cosmeceuticals and pharmaceuticals, was estimated at $7.2 Billion in the US in 2014 and is expected to rapidly grow in the coming years according to RNCOS Business Consultancy Services Global Cosmeceuticals Market report.

NuGene’s cosmeceutical and pharmaceutical products are based on proprietary stem cell based regenerative formulations derived from non-controversial, adult human stem cell derived media obtained from adipose tissue. NuGene’s exclusive products combine its in-house advancements, proprietary technologies, and patent pending formulations. The company has two patents pending covering 15 unique applications and inventions. NuGene’s goal is to leverage its extensive knowledge and expertise to develop age defying regenerative cosmeceutical skincare and hair care products in addition to pharmaceutical products based on the same regenerative science platform.

In March NUGN announced that its subsidiary corporation, NuGene BioPharma, Inc. has acquired all rights, title and interest in and to SkinGuardian®, an FDA-approved (monographed) skin protectant, antiseptic, and moisturizing topical cream.

To Find out the inside Scoop on NUGN Subscribe to Microcapdaily.com Right Now by entering your Email in the box below

NuGene BioPharma acquired all intellectual property held by SkinGuardian and its founder and owner, Chris O’Brien, relating to the SkinGuardian technology and applications. This includes the patent under which the technology is protected, the company trademark, all formulas and derivatives under the patent, clinical trial data, and any and all other rights, title and interest in and to the SkinGuardian product. Under the agreement, O’Brien will provide ongoing consultation to NuGene International, Inc.

CEO Ali Kharazmi said “We see this FDA-approved topical cream as the foundation for a variety of topical treatments we will be developing that incorporate the use of stem cells to enhance healing,” Kharazmi continued. “This is a prime example of the type of synergistic acquisitions we intend to make that will expand our range of opportunities while significantly reducing our time to market.”

On June 2 NUGN announced that Ms. Donna Queen has accepted a position on NuGene’s Board of Directors. Ms. Queen’s experience spans the biotechnology, cosmeceutical, consumer packaged goods and vision care industries and includes working with Allergan, Revlon, Bausch & Lomb, Arm & Hammer and DuPont. Her knowledge of the cosmeceutical industry was further enhanced while serving as the President of Lifeline Skin Care and ZO Skin Health.

NUGN CEO Ali Kharazmi said “We are excited to welcome Donna Queen to the Board and to draw on her expertise as a seasoned cosmeceutical executive and respected leader in our industry as we build our markets for our NuGene product offerings. Ms. Queen will bring the same thoughtful leadership advice and sage insights to NuGene that she delivered so effectively and successfully in the past. Combining her experience with Fortune 500 brands with an innovative entrepreneurial spirit and creative mindset makes her a perfect addition to our Board of Directors. I am confident that she will make a meaningful and immediate contribution to our Board and company.”

Also of importance here (thanks to Hotstocked) is the 148,200 shares of Bling Marketing that were acquired on March 27, 2014 for just $37,050. After the forward splits these shares are now 11,144,640 free trading shares of NUGN.

According to Hotstocked ”It all started in March 2014 when some investors bought a total of 148,200 shares at $0.25 apiece for $37,050. After two forward splits these shares turned into 11,144,640 free trading shares of NUGN common stock. These are most likely the shares being liquidated into the promotion.

We have a Monster Pick Coming. Subscribe Right Now!

Currently trading at a $145 million market valuation NUGN does have $1.3 million in the treasury and growing revenues reporting $723,438 in sales in 2014. The stock has transformed in recent weeks on a major hard mailer promotion to become a volume leader and top the bb’s in trades. Short term NUGN could easily move much higher, long term NUGN has no real fundamentals to back up anywhere near current valuation and could drop big. We will be updating on NUGN when more details emerge so make sure you are subscribed to Microcapdaily so you know what’s going on with NUGN.

Subscribe to Our 100% Free Penny Stock Newsletter. We Have Something Big Coming!

Disclosure: we hold no position in NUGN either long or short and we have not been compensated for this article.

NUGN preposterous Hard Mailer


More articles


Please enter your comment!
Please enter your name here

Latest article

Sign up now for our 100% FREE Penny Stock Newsletter

Privacy Policy. we will never share your email with anyone.